Free Trial

WAVE Life Sciences (WVE) SEC Filings & 10K Form

WAVE Life Sciences logo
$6.97 +0.22 (+3.26%)
Closing price 07/3/2025 03:00 PM Eastern
Extended Trading
$6.97 0.00 (0.00%)
As of 07/3/2025 04:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent WAVE Life Sciences SEC Filings

DateFilerForm TypeView
06/23/2025
3:33 PM
WAVE Life Sciences (Filer)
Form ARS
06/13/2025
7:00 PM
Verdine Gregory L. (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:44 PM
Verdine Gregory L. (Reporting)
WAVE Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2025
8:06 AM
Adage Capital Management, L.P. (Filed by)
WAVE Life Sciences (Subject)
Form SCHEDULE 13G/A
05/08/2025
6:45 AM
WAVE Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:36 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
4:00 PM
WAVE Life Sciences (Filer)
Form 10-K/A
03/26/2025
6:38 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
8:00 PM
HENRY CHRISTIAN O (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:03 PM
HENRY CHRISTIAN O (Reporting)
WAVE Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
8:00 PM
Verdine Gregory L. (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
8:05 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:10 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
4:14 PM
Vargeese Chandra (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:59 AM
WAVE Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
6:51 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
7:00 PM
Vargeese Chandra (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 PM
Francis Chris (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 PM
Moran Kyle (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
4:28 PM
BlackRock, Inc. (Filed by)
WAVE Life Sciences (Subject)
Form SCHEDULE 13G/A
01/24/2025
4:30 PM
Vargeese Chandra (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
1:00 PM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
8:00 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:09 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
5:05 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
8:00 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
7:00 PM
Francis Chris (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
WAVE Life Sciences (Subject)
Form SC 13G/A
10/30/2024
4:13 PM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
7:00 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
7:00 PM
Francis Chris (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:13 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
3:19 PM
Francis Chris (Reporting)
WAVE Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
7:34 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:15 PM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
7:00 PM
Moran Kyle (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:54 PM
GSK plc (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:47 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
WAVE Life Sciences (Subject)
Form SC 13D/A
10/01/2024
6:35 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
7:00 PM
Moran Kyle (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)

Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.

We recently interviewed Rickards to get the full story and understand how everyday Americans can pre
09/27/2024
5:09 AM
WAVE Life Sciences (Filer)
Form 424B5
09/26/2024
4:18 PM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
8:40 PM
Moran Kyle (Reporting)
WAVE Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/24/2024
4:13 PM
WAVE Life Sciences (Filer)
Form 424B3
09/24/2024
4:16 PM
WAVE Life Sciences (Filer)
Form 424B5
09/24/2024
6:34 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
5:00 PM
BOLNO PAUL (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
TAKANASHI KEN (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Wagner Heidi L (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Verdine Gregory L. (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
CORRIGAN MARK (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
HENRY CHRISTIAN O (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Tan Aik Na (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Rawcliffe Adrian (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:05 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:29 PM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:55 AM
WAVE Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:37 AM
WAVE Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
4:54 PM
Vargeese Chandra (Reporting)
WAVE Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:WVE) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners